|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.00 USD | +3.20% |
|
-0.31% | -34.03% |
| 06-19 | ASX Midday Sector Update: Healthcare Stocks Rise, Materials Sector Struggles | MT |
| 06-18 | Moderna's mRNA flu vaccine backed by FDA advisers | RE |
| Market Cap | 39.06B 34.05B 31.54B 29.52B 55.37B 3,685B 55.71B 374B 145B 1,814B 147B 143B 6,299B | P/E 2026 * |
-52.5x | P/E 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise Value | 47.9B 41.77B 38.68B 36.21B 67.91B 4,520B 68.33B 459B 178B 2,225B 180B 176B 7,725B | EV / Sales 2026 * |
3.11x | EV / Sales 2027 * | 3.01x |
| Free-Float |
99.3% | Yield 2026 * |
3.5% | Yield 2027 * | 3.6% |
Last Transcript: CSL Limited
| 1 day | +3.20% | ||
| 1 week | -0.31% | ||
| Current month | +9.13% | ||
| 1 month | +9.32% | ||
| 3 months | -20.70% | ||
| 6 months | -35.12% | ||
| Current year | -34.03% |
| 1 week | 18.41 |  | 19.23 |
| 1 month | 16.01 | | 19.23 |
| Current year | 16.01 | | 33.53 |
| 1 year | 16.01 | | 44.86 |
| 3 years | 16.01 | | 54.5 |
| 5 years | 16.01 | | 58.62 |
| 10 years | 16.01 | | 58.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gordon Naylor
CEO | Chief Executive Officer | 63 | 11/02/2026 |
Ken Lim
DFI | Director of Finance/CFO | 52 | 07/10/2025 |
Mark Hill
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 17/10/2018 | |
Marie McDonald
BRD | Director/Board Member | 70 | 14/08/2013 |
Megan Clark
BRD | Director/Board Member | 68 | 16/02/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -0.31% | - | - | 39.06B | |
| +0.33% | -0.36% | +18.76% | -22.11% | 62.05B | |
| +0.20% | -9.17% | +58.39% | +196.56% | 54.52B | |
| -3.92% | +37.40% | +37.40% | +37.40% | 41.55B | |
| -1.05% | -1.73% | +55.35% | -33.92% | 29.02B | |
| +3.50% | +28.15% | +151.81% | -50.31% | 25.38B | |
| -0.78% | -9.50% | +43.87% | +55.34% | 19.62B | |
| +1.74% | -0.39% | -2.93% | +113.90% | 16.89B | |
| -0.05% | +0.23% | +61.48% | +101.93% | 15.89B | |
| -1.66% | -0.79% | +65.68% | +341.51% | 12.98B | |
| Average | +0.15% | +1.65% | +54.42% | +82.25% | 30.88B | |
| Weighted average by Cap. | +0.14% | +0.65% | +50.38% | +63.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.39B 13.42B 12.43B 11.63B 21.82B 1,452B 21.95B 147B 57.13B 715B 57.76B 56.52B 2,481B | 15.67B 13.66B 12.65B 11.84B 22.21B 1,478B 22.35B 150B 58.17B 728B 58.82B 57.55B 2,527B |
| Net income | -893M -779M -721M -675M -1.27B -84.3B -1.27B -8.56B -3.32B -41.49B -3.35B -3.28B -144B | 1.19B 1.04B 959M 898M 1.68B 112B 1.69B 11.37B 4.41B 55.14B 4.46B 4.36B 191B |
| Net Debt | 8.85B 7.71B 7.14B 6.69B 12.54B 835B 12.62B 84.75B 32.85B 411B 33.21B 32.5B 1,427B | 8.07B 7.04B 6.52B 6.1B 11.44B 761B 11.51B 77.3B 29.96B 375B 30.29B 29.64B 1,301B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 19.00 $ | +3.20% | 371,663 |
| 17/06/26 | 18.41 $ | -2.02% | 819,199 |
| 16/06/26 | 18.79 $ | +0.80% | 422,686 |
| 15/06/26 | 18.64 $ | -2.20% | 822,793 |
| 12/06/26 | 19.06 $ | -0.42% | 270,710 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSL Stock
- CSLLY Stock
Select your edition
All financial news and data tailored to specific country editions
